{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":18,"n_cols":5,"rows_kept":18,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[11,2,11,3],[12,2,12,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910453994203321"]
[null,null,"Titolo",null,"Multi-center phase III clinical trials and NCI cooperative groups [[electronic resource] ] : workshop summary / / Margie Patlak, Sharyl Nass, and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Institute of Medicine of the National Academies"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C., : National Academies Press, 2009"]
[null,null,"ISBN",null,"1-282-00804-8"]
[{"$nulls":4},"9786612008047"]
[{"$nulls":4},"0-309-12868-4"]
[null,null,"Descrizione fisica",null,"1 online resource (135 p.)"]
[null,null,"Disciplina",null,"610.724"]
[null,null,"Soggetti",null,"Cancer - Treatment - United States"]
[{"$nulls":4},"Clinical trials"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (p. 97-101)."]
[null,null,"Nota di contenuto",null,"\"\"Reviewers\"\"; \"\"Contents\"\"; \"\"Introduction\"\"; \"\"Session 1A: Organization of the NCI Clinical Trials System\"\"; \"\"Session 1B: Lessons from Non-Cooperative Group Multi-Center Clinical Trials\"\"; \"\"Session 2: Barriers to Patient Recruitment and Physician Participation\"\"; \"\"Session 3: Data Collection Standards and Monitoring\"\"; \"\"Session 4: Costs of Cooperative Group Clinical Trials\"\"; \"\"Summary and Wrap-Up\"\"; \"\"References\"\"; \"\"Abbreviations and Acronyms\"\"; \"\"Glossary\"\"; \"\"Appendix A: Workshop Agenda\"\"; \"\"Appendix B: Workshop Speakers\"\""]
[{"$nulls":4},"\"\"Appendix C: Letter from John Niederhuber, Director of the National Cancer Institute, to Members of the National Cancer Policy Forum\"\""]